
KSP-IA
CAS No. 639074-49-0
KSP-IA( KSP-IA | KSP IA | KSPIA )
Catalog No. M15425 CAS No. 639074-49-0
A potent, specific, allosteric and cell-active inhibitor of KSP with IC50 of 11 nM; has no ihibitory activity toward other kinesins.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 1233 | Get Quote |
![]() ![]() |
50MG | 2502 | Get Quote |
![]() ![]() |
100MG | 3330 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameKSP-IA
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, specific, allosteric and cell-active inhibitor of KSP with IC50 of 11 nM; has no ihibitory activity toward other kinesins.
-
DescriptionA potent, specific, allosteric and cell-active inhibitor of KSP with IC50 of 11 nM; has no ihibitory activity toward other kinesins, includin CENP-E, MKLP-1, KIF-3A, and uKHC (IC50>50 uM); induces the formation of monoastral spindles, causes mitotic arrest in a dose-dependent manner (EC50=30 nM) in A2780 ovarian carcinoma cells; sustained KSP inhibition activates the proapoptotic protein, Bax, and both activation of the spindle checkpoint and subsequent mitotic slippage are required for Bax activation.
-
In Vitro——
-
In Vivo——
-
SynonymsKSP-IA | KSP IA | KSPIA
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetKinesin
-
RecptorKinesin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number639074-49-0
-
Formula Weight356.417
-
Molecular FormulaC21H22F2N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)[C@H](N)C(N1[C@H](C2=CC=CC=C2)C=C(C3=CC(F)=CC=C3F)C1)=O
-
Chemical Name(S)-2-amino-1-((S)-4-(2,5-difluorophenyl)-2-phenyl-2,5-dihydro-1H-pyrrol-1-yl)-3-methylbutan-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tao W, et al. Cancer Cell. 2005 Jul;8(1):49-59.
molnova catalog



related products
-
HR22C16
A potent, selective and cell permeable inhibitor of mitotic kinesin Eg5 with IC50 of 0.8 uM.
-
Merestinib
LY2801653 is an orally available, small molecule inhibitor of the proto-oncogene c-Met (Ki: 2 nM) with potential antineoplastic activity.
-
MK-0731
MK-0731 is a potent, selective kinesin spindle protein (KSP) inhibitor with IC50 of 2.2 nM, cell EC50 of 5.3 nM.